HIGHLIGHTS
- who: Naila Rabbani et al. from the Department of Basic Medical Science, College of Medicine, QU Health, Qatar University, Coventry , DX, UK have published the research work: Analysis of Serum Advanced Glycation Endproducts Reveals Methylglyoxal-Derived Advanced Glycation MG-H1 Free Adduct Is a Risk Marker in Non-Diabetic and Diabetic Chronic Kidney Disease, in the Journal: (JOURNAL) of 21/Dec/2022
- what: The authors assessed levels of AGEs in subjects with and without diabetes with normal renal function and stages 2 to 4 chronic kidney disease (CKD) to identify which AGE has the greatest . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.